![Mike Masters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mike Masters
Directeur Général chez
Masters Capital Management LLC
Profil
Mr. Michael W.
Masters is a Founder, Portfolio Manager & Chief Investment Officer at Masters Capital Management LLC.
He is on the Board of Directors at BioCircuit Technologies, Inc. and Celtaxsys, Inc. He founded Masters Capital Management in 1994 with a vision for an investment company that would align with his professional and personal values.
He is a graduate of the University of Tennessee.
Postes actifs de Mike Masters
| Sociétés | Poste | Début |
|---|---|---|
Masters Capital Management LLC
 Masters Capital Management LLC Investment ManagersFinance Masters Capital Management aims to provide long-term outsized absolute returns on invested capital. The firm manages a single investment strategy pari passu across all fund structures. The strategy generally invests in US equities and listed equity options. | Directeur Général | 01/01/1994 |
BioCircuit Technologies, Inc.
 BioCircuit Technologies, Inc. Medical SpecialtiesHealth Technology Develops non-invasive electrophysiology devices | Directeur/Membre du Conseil | - |
Anciens postes connus de Mike Masters
| Sociétés | Poste | Fin |
|---|---|---|
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Develops foundational therapies to treat inflammation in rare and orphan designated diseases | Directeur/Membre du Conseil | - |
Formation de Mike Masters
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Masters Capital Management LLC
Masters Capital Management LLC Investment ManagersFinance Masters Capital Management aims to provide long-term outsized absolute returns on invested capital. The firm manages a single investment strategy pari passu across all fund structures. The strategy generally invests in US equities and listed equity options. | Finance |
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Develops foundational therapies to treat inflammation in rare and orphan designated diseases | Health Technology |
University of Tennessee
 University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioCircuit Technologies, Inc.
BioCircuit Technologies, Inc. Medical SpecialtiesHealth Technology Develops non-invasive electrophysiology devices | Health Technology |
